Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of intranodal iHIVARNA-01 therapeutic HIV vaccine in virologically suppressed adults on stable cART
NL-OMON46133Phase 2Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2017
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of iHIVARNA-01 in human immunodeficiency virus infection (HIV), sponsored by Erasmus MC. Started Apr 2017; status: active, not recruiting.
02
Drugs
iHIVARNA-01
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON46133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46133.